Defining Target Vancomycin Trough Concentrations for Treating Staphylococcus aureus Infection in Infants Aged 0 to 90 Days.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 31180478.
- Also identified by DOI 10.1001/jamapediatrics.2019.1488 and PMC identifier 6563592.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study analyzes data from a randomized clinical trial in infants 90 days and younger to develop a pharmacokinetic model to aid physicians in maintaining minimum inhibitory concentrations of vancomycin in young infants with <i>Staphylococcus aureus</i> infection.